ORAGENICS INC (OGEN) Stock News

USA - NYSEARCA:OGEN - US6840236094 - Common Stock

1.13 USD

-0.03 (-2.59%)

Last: 11/13/2025, 2:25:04 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

OGEN Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Oragenics, Inc.

Oragenics Q3 2025 Shareholder Update

23 days ago - By: Oragenics, Inc.

Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

a month ago - By: Oragenics

Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development

3 months ago - By: Oragenics

Oragenics Q2 2025 Shareholder Update

4 months ago - By: Oragenics

Oragenics Completes Approximately $16.5 Million Offering

4 months ago - By: Oragenics

Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development

4 months ago - By: Benzinga - Mentions: APDN INNV ARTL NDRA ...

12 Health Care Stocks Moving In Monday's After-Market Session

4 months ago - By: Benzinga - Mentions: CNC EQ DBVT PLUR ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

5 months ago - By: Oragenics

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

5 months ago - By: Oragenics

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

6 months ago - By: Oragenics

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

6 months ago - By: Oragenics

Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision